loader
Delivery Location

Cabozantinib (BMS-907351) 10mM/1mL

CAS# 849217-68-1

Grade: HPLC-UV

SKU: ChemD-976-S1119-10mM/1mL-1x10-Millimeter-849217-68-1

Price per Unit
Tooltip icon
Quantity
Document Links
SDS Document
Form
Not Specified
Density
-
Appearance & Physical State
-
Color
-
Odor
-
Melting Point
-
Boiling Point
-
Freezing Point
-
Molecular Weight
501.51
Flash Point
-
pH value
-

Have a question regarding this product?

Contact Us

Shop all of the products from this supplier?

View Supplier Storefront
Country of Manufacture
-
Refractive Index
-
LogP
5.4
Exact/Molecular Mass
501.16999904 g/mol
Molar mass
-
Concentration
-
Water Content
-
Acid Content
-
Viscosity
-
Cloud Point
-
Specific heat of liquid
-
Thermo Stability
-
Oxygen Stability
-
Water Stability
-
Vapor Pressure
-
Assay (Gas chromatography)
-
Molecular formula
C28H24FN3O5
Soluble
COMETRIQ is practically insoluble in water.
Max Handling Temp
-
Recommended Dosage
-

Cabozantinib (BMS-907351) 10mM/1mL for Sale Online

Selleck Chemicals LLC manufactures Cabozantinib (BMS-907351) 10mM/1mL, for sale through ChemDirect.
Selleck Chemicals LLC sells Cabozantinib (BMS-907351) 10mM/1mL with a product grade of HPLC-UV and percent purity of 97%. Cabozantinib (BMS-907351) 10mM/1mL is for sale online in 1x10 Milligram, 1x10 Millimeter, 1x200 Milligram, 1x50 Milligram, and 1x5 Milligram quantities. Cabozantinib (BMS-907351) 10mM/1mL has the molecular formula C28H24FN3O5 and a chemical weight of 501.51. Cabozantinib (BMS-907351) 10mM/1mL is also called xl184, cometriq, xl-184, bms-907351, xl 184, bms 907351, cabozantinib (xl184\\, bms-907351), unii-1c39jw444g, chebi:72317, xl-184 free base and bms907351. It's CAS (Chemical Abstracts Service) Registry Number is 849217-68-1.

Save time and money when you buy Cabozantinib (BMS-907351) 10mM/1mL online through ChemDirect.

About the Supplier

Selleck Chemicals LLC Selleck's Bioactive Compound Libraries consist of over 8,000 small molecules with validated biological and pharmacological activities. The safety and effectiveness of these molecules has been demonstrated through preclinical and clinical research and many of them are FDA-approved compounds.